UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Journal of clinical oncology, 2013-01, Vol.31 (3), p.344-350

2013

Volltextzugriff (PDF)

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1268-1274

2009

Volltextzugriff (PDF)

Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas

Neuro-oncology (Charlottesville, Va.), 2013-05, Vol.15 (5), p.595-606

2013

Volltextzugriff (PDF)

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

Journal of clinical oncology, 2009-12, Vol.27 (35), p.5881-5886

2009

Volltextzugriff (PDF)

Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study

Journal of clinical oncology, 2008-10, Vol.26 (28), p.4659-4665

2008

Volltextzugriff (PDF)

Pregnancy increases the growth rates of world health organization grade II gliomas

Annals of neurology, 2010-03, Vol.67 (3), p.398-404

2010

Volltextzugriff (PDF)

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951

European journal of cancer (1990), 2013-11, Vol.49 (16), p.3477-3485

2013

Volltextzugriff (PDF)

Health-Related Quality of Life in Patients Treated for Anaplastic Oligodendroglioma With Adjuvant Chemotherapy: Results of a European Organisation for Research and Treatment of Cancer Randomized Clinical Trial

Journal of clinical oncology, 2007-12, Vol.25 (36), p.5723-5730

2007

Volltextzugriff (PDF)

Prognostic Value of Health-Related Quality-of-Life Data in Predicting Survival in Patients With Anaplastic Oligodendrogliomas, From a Phase III EORTC Brain Cancer Group Study

Journal of clinical oncology, 2007-12, Vol.25 (36), p.5731-5737

2007

Volltextzugriff (PDF)

Influence of pregnancy in the behavior of diffuse gliomas: clinical cases of a French glioma study group

Journal of neurology, 2009-12, Vol.256 (12), p.2014-2020

2009

Volltextzugriff (PDF)

Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families

Oncogene, 2002-10, Vol.21 (44), p.6841-6847

2002

Volltextzugriff (PDF)

IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

Clinical cancer research, 2010-03, Vol.16 (5), p.1597-1604

2010

Volltextzugriff (PDF)

Molecular study of the perforin gene in familial hematological malignancies

Hereditary cancer in clinical practice, 2011-09, Vol.9 (1), p.9-9, Article 9

2011

Volltextzugriff (PDF)

Une galénique innovante qui optimise l'absorption du fentanyl: PecFent® : un nouvel atout dans le traitement des accès douloureux paroxystiques liés au cancer

Douleurs, 2011, Vol.12, p.8-9

FRENAY, Marc

2011

Volltextzugriff (PDF)

PecSys™ et PecFent ® : apport de la galénique dans l’amélioration de la performance du fentanyl dans le traitement des accès douloureux paroxystiques (ADP)

Douleurs, 2010-12, Vol.11 (6), p.307-311

Frenay, Marc

2010

Volltextzugriff (PDF)

Bevacizumab: Is the lower the better for glioblastoma patients in progression?

Bulletin du cancer, 2018-12, Vol.105 (12), p.1135-1146

2018

Volltextzugriff (PDF)

Cancer and multiple sclerosis in the era of disease-modifying treatments

Journal of neurology, 2011-07, Vol.258 (7), p.1304-1311

2011

Volltextzugriff (PDF)

LTBK-12. EORTC 26951, RANDOMIZED STUDY OF ADJUVANT PCV AFTER 59.4 GY RADIOTHERAPY: VERY LONG TERM FOLLOW-UP

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi285-vi285

2019

Volltextzugriff (PDF)

Renal failure secondary to thrombotic complications of suprarenal inferior vena cava filter in cancer patients

Cardiovascular and interventional radiology, 2001-07, Vol.24 (4), p.257-259

2001

Volltextzugriff (PDF)

Une galénique innovante qui optimise l’absorption du fentanyl

Douleurs, 2011-10, Vol.12 (5), p.H8-H9

2011

Volltextzugriff (PDF)

BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis

Genetics in medicine, 2012-05, Vol.14 (5), p.527-534

2012

Volltextzugriff (PDF)

Biocomputing: numerical simulation of glioblastoma growth using diffusion tensor imaging

Physics in medicine & biology, 2008-02, Vol.53 (4), p.879-893

2008

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(140)

Sprache

Englisch
(128)
Französisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neurology
(20)
Journal Of Clinical Oncology
(12)
Multiple Sclerosis
(9)
Archives Of Neurology
(4)
Brain
(4)
Annals Of Clinical And Translational Neurology
(3)
Breast Cancer Research And Treatment
(3)
Bulletin Du Cancer
(3)
Douleurs
(3)
Jama Neurology
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study

Pregnancy increases the growth rates of world health organization grade II gliomas

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951

Health-Related Quality of Life in Patients Treated for Anaplastic Oligodendroglioma With Adjuvant Chemotherapy: Results of a European Organisation for Research and Treatment of Cancer Randomized Clinical Trial

Prognostic Value of Health-Related Quality-of-Life Data in Predicting Survival in Patients With Anaplastic Oligodendrogliomas, From a Phase III EORTC Brain Cancer Group Study

Influence of pregnancy in the behavior of diffuse gliomas: clinical cases of a French glioma study group

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO)

Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families

IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

Molecular study of the perforin gene in familial hematological malignancies

Une galénique innovante qui optimise l'absorption du fentanyl: PecFent® : un nouvel atout dans le traitement des accès douloureux paroxystiques liés au cancer

PecSys™ et PecFent ® : apport de la galénique dans l’amélioration de la performance du fentanyl dans le traitement des accès douloureux paroxystiques (ADP)

Bevacizumab: Is the lower the better for glioblastoma patients in progression?

Cancer and multiple sclerosis in the era of disease-modifying treatments

LTBK-12. EORTC 26951, RANDOMIZED STUDY OF ADJUVANT PCV AFTER 59.4 GY RADIOTHERAPY: VERY LONG TERM FOLLOW-UP

Renal failure secondary to thrombotic complications of suprarenal inferior vena cava filter in cancer patients

Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families

Une galénique innovante qui optimise l’absorption du fentanyl

BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis

Biocomputing: numerical simulation of glioblastoma growth using diffusion tensor imaging

Suchergebnisse filtern